Dracen Pharmaceuticals, Inc. Email Format
Pharmaceutical ManufacturingNew York, United States2-10 Employees
Dracen Pharmaceuticals, Inc. is a privately held biotechnology company based in New York City, New York. It operates in the pharmaceutical manufacturing sector and pursues cancer therapies through an immuno-metabolism-based approach, with potential applicability across a range of tumor types. The organization focuses on research and development to advance oncology programs with potential applicability across multiple indications. The company has engaged in partnerships to support its research program, including a 2020 collaboration with Fibrofoundation to enable clinical research using the experimental prodrug DRP-104 in fibrolamellar hepatocellular carcinoma. This collaboration illustrates its reliance on external partnerships to progress its clinical investigation efforts.